¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"disease frequency survey"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • microdrepanocytic disease
    ÀÛÀº³´ÀûÇ÷±¸º´
  • neoplastic disease
    ½Å»ý¹°º´, Á¾¾çº´
  • nervous disease
    ½Å°æ°èÁúȯ, ½Å°æº´
  • neurohypophysial disease
    ½Å°æ³úÇϼöüº´
  • neuromuscular disease
    ½Å°æ±Ù(À°)º´
  • neuropathic joint disease
    ½Å°æº´¼º°üÀýº´
  • notifiable disease
    ½Å°í´ë»óº´, ¹ß»ýº¸°íº´
  • nutritional deficiency disease
    ¿µ¾ç°áÇ̺´
  • nutritional disease
    ¿µ¾çº´, ¿µ¾ç¼ºÁúȯ
  • occlusive cerebrovascular disease
    Æó¼â³úÇ÷°üº´, Æó¼â³úÇ÷°üÁúȯ
  • occupational dental disease
    Á÷¾÷Ä¡°úº´
  • occupational disease
    Á÷¾÷º´
  • organic disease
    ±âÁúº´
  • Osgood-Schlatter disease
    ¿À½º±Â-½¶¶óÅͺ´
  • obstructive pulmonary disease
    Æó¼âÆóº´
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • parasitic disease
    ±â»ýÃæº´
  • paroxysmal disease
    ¹ßÀÛº´
  • pelvic inflammatory disease
    °ñ¹Ý³»°¨¿°
  • periapical disease
    Ä¡±Ù´ÜÁÖÀ§º´, Ä¡¾Æ³¡ÁÖÀ§º´
  • pericardial disease
    ½ÉÀ帷º´
  • periodontal disease
    Ä¡ÁÖº´, Ä¡±Ù¸·º´
  • peripheral vascular disease
    ¸»ÃÊÇ÷°üº´
  • pigeon breeder¡¯s disease
    ºñµÑ±â»çÀ°»çº´
  • pneumatic hammer disease
    ¾ÐÂø°ø±âÇØ¸ÓÁõ
  • polycystic kidney disease
    ¹µÁÖ¸Ó´ÏÄáÆÏº´, ´Ù³¶ÄáÆÏº´
  • posttransplant lymphoproliferative disease
    À̽ÄÈĸ鿪Áõ½Äº´
  • prenatal disease
    Ãâ»ýÀüº´
  • primary pigmented nodular adrenocortical disease
    ÀÏÂ÷»ö¼ÒÄ§Âø°áÁ¤ºÎ½Å°ÑÁúº´
  • professional disease
    Á÷¾÷º´
  • protozoan disease
    ¿øÃ溴
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • functional cardiovascular disease
    ±â´É¼º ½ÉÇ÷°üº´.
  • fungous disease
    Áø±ÕÁúȯ, °õÆÎÀÌÆò
  • gamma-chain disease
    °¨¸¶¼âº´, Gamma-chain º´
  • gastric vertigo =trousseau disease
    À§(¼º)Çö±â
  • gauchers disease
    °í½¦º´, Gaucher º´
  • generalized obstructive lung disease
    ¹ü¹ß¼º Æó¼â¼º ÆóÁúȯ(ÛñÛ¡àõøÍáð
  • gestational trophoblastic disease
    Àӽżº¿µ¾ç¸ð¼¼Æ÷Áúȯ(¡­ç½å×Ù½á¬øàòðü´)
  • glomerular disease
    »ç±¸Ã¼Áúº´
  • glomerular disease
    »ç±¸Ã¼Áúȯ(ÞêϹô÷òðü´)
  • glucose storage disease
    ´çÃàÀûÁúȯ.
  • glucuronidase deficiency disease
    ±Û·çÅ¥·Î´Ïµ¥À̽º °áÇÌÁõ
  • glycogen storage disease
    ±Û¸®ÄÚ°ÕÃàÀû Áúȯ.
  • glycogen storage disease
    ´ç¿ø ÃàÀûÁúȯ(ÓØê«õëîÝòðü´)
  • glycogen storage disease
    ±Û¸®ÄÚ°ÕÃàÀûÁúȯ
  • graft versus host disease
    ´ë¼÷ÁÖÀÌ½ÄÆíÁúȯ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • congenital heart disease
    ¼±Ãµ¼º ½ÉÁúȯ(¡­ãýòðü´)
  • connate disease
    ¼±Ãµº´(à»ô¸Ü»).
  • connective tissue disease
    °áÇÕÁ¶Á÷ Áúȯ(¡­òðü´)
  • connective tissue disease,mixed
    È¥ÇÕ¼º(ûèùêàõ)
  • constitutional disease
    üÁú¼º Áúȯ.
  • constrictive heart disease
    ±³Âø¼º ½ÉÁúȯ(¡­àõãýòðü´).
  • consumption disease
    ¼Ò¸ð¼º Áúȯ.
  • contagious disease
    Àü¿°º´
  • contagious disease
    (Á¢ÃË)Àü¿°º´(ïÈõºîîæøÜ»), (Á¢ÃË)°¨¿°Áõ(¡­Êïæøñø).
  • copper storage disease
    µ¿ÀúÀåÁúȯ(ÔÞîÍíúòðü´).
  • coris disease
    ÄÚ¸®º´(¡­Ü»)
  • coronary artery disease
    °ü(»ó)µ¿¸ÆÁúȯ(¡­òðü´).
  • coronary artery disease
    ½ÉÀ嵿¸ÆÁúȯ(ãýíôÔÑØæòðü´)
  • coronary disease
    °ü(»ó)Áúȯ(ήßÒòðü´).
  • coronary heart disease
    °ü(»ó)µ¿¸Æ½ÉÁúȯ(ήßÒÔÑØæãýòðü´).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 20
Fmed median frequency
FR failure rate; film-screen radiograph; fasciculus retroflexus; febrile reaction; feedback regulation;...
Fr fracture; francium; franklin [unit charge]; French; frequency or frequent
freq frequency
FTFT fast time frequency transform
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 20
ELF MF extremely low frequency magnetic field
F(0) frequency
F(c) frequency
F(n) frequency
FM frequency
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • sporadic disease
    »ê¹ß Áúȯ, »ê¹ß¼º Áúȯ
  • sterility disease
    ºÒÀÓ¼º Áúȯ
  • Still's disease
    ½ºÆ¿ Áúȯ, ½ºÆ¿ º´
    µ¿ÀǾî=juvenile rheumatoid arthritis. 1. Ç÷û¿¡ ÀÌ»óÀÌ ³ªÅ¸³ªÁö ¾Ê´Â °üÀý¿°À¸·Î¼­ Á¾Á¾ ¹ß¿­°ú ¸²ÇÁÀýº´ÁõÀÌ µ¿¹ÝµÇ¸ç 16¼¼ ÀÌÀü¿¡ ½ÃÀÛÇÏ´Â °üÀý¿°ÀÇ 70%¸¦ Â÷ÁöÇÑ´Ù. 2. ¼Ò¾Æ¼º ¸²ÇÁÁ¾ ºñÁ¾¼º À§Ãà ´Ù¹ß¼º °üÀý¿°. ¼Ò¾Æ¿¡ »ý±â´Â ¸¸¼º ´Ù¹ß¼º °üÀý¿°ÀÇ ÀÏÁ¾. ¸²ÇÁÀý Á¾Ã¢, ºñÁ¾, ºÒ±ÔÄ¢¼º ¹ß¿­ÀÌ Æ¯Â¡ÀÌ´Ù.
  • storage pool disease
    ÀúÀåÁ¶º´
    ÀÀÁýÁ¦, ¿¡Çdz×ÇÁ¸°, ¿ÜÀμº ADP, Æ®·Òºó µî¿¡ ¹ÝÀÀÇÏ¿© ADP¸¦ ¹æÃâÇÏ´Â Ç÷¼ÒÆÇ ±â´É ºÎÀü¿¡ ÀÇÇÑ Ç÷¾× ÀÀ°í Àå¾Ö, °¡º­¿î ÃâÇ÷ Áõ»ó, ÃâÇ÷ ½Ã°£ Áö¿¬, ±³¿øÁúÀ̳ª Æ®·Òºó¿¡ ´ëÇÑ ÀÀÁý ¹ÝÀÀÀÇ °¨Å𸦠Ư¡À¸·Î ÇÑ´Ù.
  • stripe disease
    ¼±Á¶º´
  • strumpell's disease Ãø»è °æÈ­ÁõÀÇ À¯ÀüÇüÀ¸·Î ÀÌ Áúº´¿¡¼­ÀÇ °æ·ÃÀº ÁÖ·Î ¹ß¿¡ ÇÑÁ¤µÇ¾î ÀϾ´Ù.

    strychnine

    ½ºÆ®¸®Å©´Ñ
    ±Øµµ·Î µ¶¼ºÀÌ °­ÇÑ ¾ËÄ®·ÎÀ̵å. ÁÖ·Î Strychnos nuxvomica ¹× StrychnosÀÇ ´Ù¸¥ Á¾¿¡¼­ ¾ò¾îÁö¸ç, ½Å°æ Ãæµ¿ÀÇ Á¢ÇպΠÈĺÎÀÇ ¾ïÁ¦¸¦ Â÷´ÜÇÔÀ¸·Î½á ÁßÃß ½Å°æ°èÀÇ ¸ðµç ºÎºÐÀ» ÈïºÐ½ÃŲ´Ù. ÁßÃß ½Å°æ°èÀÇ ÈïºÐÁ¦·Î »ç¿ëµÇ°í ÀÖÀ¸¸ç, ÀÌÀü¿¡´Â °í¹Ì °­ÀåÁ¦, ¼øÈ¯ ÀÚ±ØÁ¦·Î ¶Ç´Â ¼³»çÁ¦¿Í ¾Æ¿ï·¯ »ç¿ëµÇ¾ú´Ù.
  • subacute disease
    ¾Æ±Þ¼º Áúȯ
  • systemic degenerative joint disease
    Àü½Å¼º ÅðÇ༺ °üÀý Áúȯ
  • tay-sachs disease Èæ³»À强 °¡Á·¼º ¹éÄ¡ÀÇ ¿µ¾ÆÇü.

    tazettine

    ŸÁ¦Æ¾
  • temporomandibular joint disease
    ÃøµÎÇϾǰüÀý Áúȯ
  • Thomsen's disease : ¼±Ãµ¼º ±Ù±äÀåÁõ.

    thoracalgia

    È亮Åë
  • thromboembolic disease
    Ç÷Àü »öÀü¼º Áúȯ
  • thyrotoxic heart disease
    °©»ó¼± Áßµ¶¼º ½ÉÀ庴
    °©»ó¼± ±â´É Ç×Áø°ú °ü·ÃÇÑ ½ÉÀå ÁúȯÀ¸·Î ½É¹æ ¼¼µ¿. ½ÉÀå È®´ë, ¿ïÇ÷¼º ½ÉºÎÀü µîÀÌ ³ªÅ¸³­´Ù.
  • tropical disease
    ¿­´ëº´
    °í¿Â ´Ù½ÀÇÏ°í ¹Ì°³¹ß Áö¿ªÀÌ ¸¹Àº ¿­´ë Áö¹æ¿¡¼­ ¸¹ÀÌ ¹ß»ýÇÏ´Â º´. ´ëÇ¥ÀûÀÎ °ÍÀ¸·Î´Â ¾Æ¸Þ¹Ù Àû¸®, Ä®¶ó¾ÆÀÚ¸£
  • tubulo-interstitial disease
    ¼¼´¢°ü-°£Áú¼º Áúȯ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
refsum disease A chronic progressive peripheral neuropathy which is probably inherited in an autosomal recessive manner. Some of the manifestations of this disorder are atypical retinitis pigmentosa, cerebellar ataxia, and increased cerebrospinal protein levels. Excessive phytanic acid storage has been found in most cases. Onset of symptoms usually occurs in early childhood. Infantile refsum disease (see peroxisomal disorders) differs in that it also includes mental retardation, dysmorphic features, peroxisomal deficiency, and very early onset.
(12 Dec 1998)
refsum's disease A genetic disorder of the fatty acid phytanic acid which accumulates and causes a number of progressive problems including polyneuritis (inflammation of numerous nerves), diminishing vision (due to retinitis pigmentosa), and wobbliness (ataxia) caused by damage to the cerebellar portion of the brain (cerebellar ataxia).
(12 Dec 1998)
Vincent's disease <disease> An acute or recurrent form of gingivitis of young to middle-aged adults characterised by red and painful gums, fetid breath and gum destruction. Other features may include fever and enlargement of the regional lymph nodes.
Pathogenesis of this condition is thought to be secondary to a fusiform bacillus and spirochetal (Treponema vincentii) microorganisms.
(14 Oct 1997)
McArdle disease <disease> Glycogen storage disease in which the defective enzyme is muscle phosphorylase.
(18 Nov 1997)
McArdle-Schmid-Pearson disease Glycogenosis due to muscle glycogen phosphorylase deficiency, resulting in accumulation of glycogen of normal chemical structure in muscle.
Synonym: McArdle's disease, McArdle's syndrome, McArdle-Schmid-Pearson disease, myophosphorylase deficiency glycogenosis.
(05 Mar 2000)
McArdle's disease Glycogenosis due to muscle glycogen phosphorylase deficiency, resulting in accumulation of glycogen of normal chemical structure in muscle.
Synonym: McArdle's disease, McArdle's syndrome, McArdle-Schmid-Pearson disease, myophosphorylase deficiency glycogenosis.
(05 Mar 2000)
Glanzmann's disease <haematology> A form of congenital platelet functional defect that result in prolongation of the bleeding time. Characteristics include mucosal and post-operative bleeding that may be severe.
(17 Dec 1997)
Glasser's disease <disease> A fibrinous polyserositis, polyarthritis, and meningitis of pigs caused by the bacterium Haemophilus parasuis.
(05 Mar 2000)
Virchow's disease A condition, either congenital or acquired, in which the head is abnormally large; usually applied to an adult skull with a capacity of over 1450 ml.
Synonym: leontiasis ossea, macrocephaly, macrocephalia, megacephalia, megalocephaly, megalocephalia, Virchow's disease.
Origin: mega-+ G. Kephale, head
(05 Mar 2000)
mechanobullous disease This represents a group of rare inherited disorders in which blistering of the skin occurs in response to skin trauma. Large fluid-filled blisters can occur in response to injury, skin rubbing, chafing or even increases in room temperature. Secondary bacterial infection of the blisters is common. Complications include oesophageal stricture, infections, loss of function of hands and feet and malnutrition. The dermatologist is the expert in the evaluation and treatment of this disorder.
(27 Sep 1997)
reiter's disease A triad of nongonococcal urethritis followed by conjunctivitis and arthritis, of unknown aetiology.
(12 Dec 1998)
virus X disease A term applied to a number of virus disease's of obscure aetiology, e.g., Australian X disease (Murray Valley encephalitis).
(05 Mar 2000)
visceral disease virus <virology> Probably the most widespread of the Herpetoviridae group.
Infected cells enlarge and have a characteristic inclusion body (composed of virus particles) in the nucleus. Causes disease only in utero (leading to abortion or stillbirth or to various congenital defects), although can be opportunistic in the immunocompromised host.
Patients who have been exposed to the virus will remain cytomegalovirus IgG positive.
Acronym: CMV
(30 Sep 1997)
Pauzat's disease Osteoplastic periostitis or fatigue fractures of the metatarsal bones, caused by excessive marching.
(05 Mar 2000)
Pavy's disease Cyclic or recurrent physiologic albuminuria.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 20
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 20
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 20
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 20
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 20
ÅëÇÕ°Ë»ö ¿Ï·á